Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD

MJBizDaily
By Pamela MooreOct 26, 2020, 4:04 pm274 pts
A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64-percent increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—have a chemical structure similar to THC and are often…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas Senate Passes Consumable THC Hemp Ban During Special Session 61

Survey: Nearly Half of Vape Users Say Lab Testing and Safety Certifications Have Most Influence on Brand Trust 60

Cybersecurity Researcher Uncovers Over 957,000 Medical Cannabis Patient Records on Unsecured Database 59

Tilray Is a Dangerous Stock 56

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.